Back to search

Article

Targeting tumor cell-derived CCL2 as a strategy to overcome bevacizumab resistance in ETV5+ colorectal cancer

2020-04-29

Abstract excerpt

<h4>Background: </h4> ETV5 mediated angiogenesis was dependent on PDGF-BB/PDGFR-β/Src/STAT3/VEGFA pathway in colorectal cancer (CRC) in our previous study. However, whether ETV5 affects effect of antiangiogenic therapy in CRC requires further investigation. Methods GSEA analysis and a series of experiments were performed to identify the critical candidate gene involved in bevacizumab resistance, and further explo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2ac9995-92b5-53fc-b769-3e3724845e66
DOI
10.21203/rs.3.rs-25020/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting tumor cell-derived CCL2 as a strategy to overcome bevacizumab resistance in ETV5+ colorectal cancerDOI 10.21203/rs.3.rs-25020/v1
Select a neighboring publication to make it the new centre.